Medicare Enrolled

Dr. Syed Sadiq, M.D.

Gastroenterology · Fort Worth, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
900 W MAGNOLIA AVE, Fort Worth, TX 76104
8178707300
In practice since 2005 (20 years)
NPI: 1144211707 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sadiq from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sadiq? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sadiq

Dr. Syed Sadiq is a gastroenterology in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. Sadiq performed 761 Medicare services across 727 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sadiq received a total of $9,931 from 53 pharmaceutical and/or device companies across 451 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sadiq is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 38% volume in TX$ $9,931 industry payments

Medicare Practice Summary

Medicare Utilization ↗
761
Medicare services
Top 38% in TX for gastroenterology
727
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~38 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Removal of polyps or growths of large bowel using an endoscope with mechanical snare129$201$1,067
Upper GI endoscopy with biopsy113$50$680
Office visit, established patient (30-39 min)110$92$217
New patient office visit (45-59 min)78$99$333
New patient office or other outpatient visit, 15-29 minutes72$40$151
Office visit, established patient (20-29 min)54$63$148
Insertion of guide wire with dilation of esophagus using a flexible endoscope37$85$701
Initial hospital admission, high complexity35$135$411
Colonoscopy with biopsy34$93$847
Hospital follow-up visit, high complexity31$93$212
Colorectal cancer screening; colonoscopy on individual at high risk24$177$778
New patient office visit (30-44 min)20$79$219
Diagnostic exam of large bowel using a flexible endoscope13$131$781
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk11$178$781
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,931
Total received (2018-2024)
Avg $1,419/year across 7 years
Top 20% in TX for gastroenterology
53
Companies
451
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,237 (82.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,616 (16.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$78 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,602
2023
$1,344
2022
$1,010
2021
$696
2020
$366
2019
$1,149
2018
$2,763

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Shionogi Inc
$1,684
ABBVIE INC.
$1,034
Boston Scientific Corporation
$984
Janssen Biotech, Inc.
$893
AbbVie, Inc.
$874
AbbVie Inc.
$845
Celgene Corporation
$440
Takeda Pharmaceuticals U.S.A., Inc.
$333
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$281
PFIZER INC.
$271
QOL Medical, LLC
$252
Ferring Pharmaceuticals Inc.
$208
Regeneron Healthcare Solutions, Inc.
$138
Daiichi Sankyo Inc.
$132
Cook Medical LLC
$118
Ironwood Pharmaceuticals, Inc
$116
VIVUS LLC
$95
Lilly USA, LLC
$88
RedHill Biopharma Inc.
$84
Ardelyx, Inc.
$72
Merck Sharp & Dohme Corporation
$65
Ethicon US, LLC
$62
Madrigal Pharmaceuticals
$59
E.R. Squibb & Sons, L.L.C.
$55
Intercept Pharmaceuticals, Inc.
$54
Janssen Scientific Affairs, LLC
$47
IRONWOOD PHARMACEUTICALS, INC
$45
Enterra Medical, Inc.
$44
Amgen Inc.
$43
Organon LLC
$40
Fresenius Kabi USA, LLC
$36
Gilead Sciences, Inc.
$32
Merck Sharp & Dohme LLC
$29
Nestle HealthCare Nutrition Inc.
$28
GENZYME CORPORATION
$27
INTERCEPT PHARMACEUTICALS, INC.
$27
Braintree Laboratories, Inc.
$26
Prometheus Laboratories Inc.
$24
Allergan Inc.
$24
Amarin Pharma Inc.
$22
Allergan, Inc.
$21
Romark Laboratories, LC
$21
Phathom Pharmaceuticals, Inc.
$20
Otsuka America Pharmaceutical, Inc.
$17
UCB, Inc.
$16
NESTLE HEALTHCARE NUTRITION INC.
$16
Organon Llc
$15
Shire North American Group Inc
$15
AstraZeneca Pharmaceuticals LP
$15
Ipsen Biopharmaceuticals, Inc
$15
Celltrion USA Inc.
$14
Endo Pharmaceuticals Inc.
$13
Napo Pharmaceuticals Inc
$5
Top 3 companies account for 37.3% of total payments
Associated products mentioned in payments ›
AVSOLA · Alinia Tablets 500mg 30 count bottle · CLENPIQ · COOK MEDICAL HEMOSPRAY · CRE PRO · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · Entyvio · Epclusa · GATTEX · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · IQIRVO · LINX Reflux Management System · LINZESS · Linzess · MOVANTIK · Mavyret · Motegrity · Movantik · Mulpleta · Mytesi · NASCOBAL · OCALIVA · OMVOH · QSYMIA · Qsymia · REBYOTA · REMICADE · RENFLEXIS · RESMETIROM · REXULTI · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · VELSIPITY · VIBERZI · VOQUEZNA · Vascepa · Viekira · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,305 per 100 Medicare services performed
Looking for a gastroenterology in Fort Worth?
Compare gastroenterologys in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
124
Per 100K population
5.8
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sadiq is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 20%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sadiq experienced with removal of polyps or growths of large bowel using an endoscope with mechanical snare?
Based on Medicare claims data, Dr. Sadiq performed 129 removal of polyps or growths of large bowel using an endoscope with mechanical snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sadiq receive payments from pharmaceutical companies?
Yes. Dr. Sadiq received a total of $9,931 from 53 companies across 451 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sadiq's costs compare to other gastroenterologys in Fort Worth?
Dr. Sadiq's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sadiq) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →